MedPath

Relevance of Biomarkers in the Process of Weaning

Conditions
Duration of Weaning
Registration Number
NCT01341561
Lead Sponsor
Heidelberg University
Brief Summary

The purpose of the study is to examine the relevance of biochemical markers (specific pulmonary and cardiac markers and markers of endogenous stress) in the process of weaning in patients with artificial ventilation.

Detailed Description

Artificially ventilated patients on our intensive care unit will be monitored if specific biomarkers have a relevance in risk stratification, optimizing therapy, outcome and success in the process of weaning. Therefore, consecutively, specific blood parameters will be taken at time of intubation,day 1 of weaning and extubation.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Written informed consent
  • Able and willing to understand the protocol
  • At least 18 years or older
Exclusion Criteria
  • Not fulfilling inclusion criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
success of weaningparticipants will be followed for the duration of hospital stay, an expected average of 30days

primary outcome measure is the success of weaning during hospital stay. Duration of hospital stay is estimated between 1-60days, in average 30days. Criteria is spontaneous breathing.

Secondary Outcome Measures
NameTimeMethod
follow up12 months

Follow up is done after 12 months to check major adverse cardiac or pulmonary events (death, myocardial infarction, re-hospitalisation)

Trial Locations

Locations (1)

Intensive Care Unit, University of Heidelberg

🇩🇪

Heidelberg, Baden-Württemberg, Germany

© Copyright 2025. All Rights Reserved by MedPath